Daniel E. Morse insider trades: Stellar Biotechnologies (SBOT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 12, 2018 | SBOT | ↓ Sell | 7,047 | $1.31 | $9K | Direct | Oct 12, 2018 (0d) |
| Mar 29, 2018 | SBOT | ↓ Sell | 4,366 | $0.81 | $4K | Joint Account with Spouse | Apr 3, 2018 (5d) |
| Mar 12, 2018 | SBOT | ↓ Sell | 24,500 | $0.80 | $19K | Joint Account with Spouse | Mar 14, 2018 (2d) |
| Feb 22, 2018 | SBOT | ↓ Sell | 7,800 | $0.78 | $6K | Joint Account with Spouse | Mar 14, 2018 (20d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Daniel E. Morse's insider trades
Daniel E. Morse is an insider at Stellar Biotechnologies (SBOT). Since Feb 22, 2018, Daniel has reported no open-market purchases and 4 sales worth $38K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SBOT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.